Near-field airborne particle concentrations in young children undergoing high-flow nasal cannula therapy: a pilot

E T Gall1, A Laguerre1, M Noelck2

  • 1Department of Mechanical and Materials Engineering, Portland State University, Portland, OR, USA.

Insights

High-flow nasal cannula therapy (HFNC) did not increase near-patient aerosol particle counts in children. This study suggests HFNC use may not significantly elevate healthcare worker exposure risk to airborne pathogens.

Area of Science:

  • Pediatric respiratory care
  • Infectious disease transmission
  • Aerosol science

Background:

  • High-flow nasal cannula therapy (HFNC) is utilized in pediatric care but may pose risks to healthcare workers due to increased aerosol generation, particularly concerning SARS-CoV-2.
  • Understanding aerosol dispersion during HFNC is crucial for implementing effective infection control measures.

Purpose of the Study:

  • To investigate if HFNC use in children generates more aerosols in the near-field environment.
  • To determine if HFNC flow rate correlates with aerosol particle concentration and dispersion.

Main Methods:

  • Particle concentrations and dispersion were measured at various distances from pediatric subjects (4 weeks to 24 months) receiving HFNC at different flow rates.
  • Near-field measurements within 0.5m were adjusted using far-field room measurements, with CO2 and humidity also monitored.
  • The study focused on aerosols with a diameter of 0.3-10 μm.

Main Results:

  • Near-field breathing plane aerosol concentrations (0.3-10 μm) were slightly elevated by the patient's presence without HFNC compared to the room's far-field.
  • Despite observed variability in particle emission and dispersion among subjects, HFNC use at any flow rate showed no association with increased near-field particle counts.
  • Elevated CO2 levels confirmed measurements were taken within the breathing plane.

Conclusions:

  • The particle sampling methodology is practical for hospital settings, with adjusted near-patient aerosol and CO2 levels potentially serving as exposure risk proxies.
  • This pilot study indicates that HFNC in pediatric patients does not significantly impact near-patient aerosol levels (0.3-10 μm) or CO2 concentrations.
Abstract